While sermorelin's GI side effects are generally mild, combination therapy might increase symptom burden
The agency specifically noted that some patients were told by prescribers or telehealth platforms that topical application carried no risk of systemic side effects
Levagina, G.M., Alikin, Yu.S., Masycheva, V.I., Danilenko, E.D., Fadina, V.A., and Ignatev, G.M., Long-acting interferon inducer, RF Patent RU 2172631, 2001
121,134 GIP, another insulin secretion agonist, helps release insulin, particularly after eating, enhancing the effects of GLP-1 and thereby improving the overall therapeutic efficacy of the drug
Primary taxonomy codes that begin with `27' represent hospital units
A faded or pale colour can indicate loss of copper coordination and reduced product integrity